Dozens of drug manufacturers—including Johnson & Johnson and its subsidiaries Janssen Pharmaceutical Products, Ortho Biotech Products, McNeil-PPC, and Centocor—paid the state of Hawaii more than $82.7 million in settlements to resolve claims relating to the marketing and selling of prescription drugs and the manufacturers’ reporting of average wholesale price. The state alleged that for more than a decade, the drug companies had published inflated prices for prescription drugs, causing the overpayment of millions of dollars in drug costs. J&J’s share of the settlement totaled $5.2 million.